Terms: = Pancreatic cancer AND SDHC, CYBL, 6391, ENSG00000143252, SDH3, PGL3, QPS1, CYB560
12 results:
1. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
[TBL] [Abstract] [Full Text] [Related]
2. [Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].
Agaimy A
Pathologe; 2016 Mar; 37(2):144-52. PubMed ID: 26979428
[TBL] [Abstract] [Full Text] [Related]
3. Succinate Dehydrogenase (SDH)-Deficient pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.
Niemeijer ND; Papathomas TG; Korpershoek E; de Krijger RR; Oudijk L; Morreau H; Bayley JP; Hes FJ; Jansen JC; Dinjens WN; Corssmit EP
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1386-93. PubMed ID: 26259135
[TBL] [Abstract] [Full Text] [Related]
4. The superoxide dismutase 1 3'UTR maintains high expression of the SOD1 gene in cancer cells: The involvement of the RNA-binding protein AUF-1.
Zhang S; Xue J; Zheng J; Wang S; Zhou J; Jiao Y; Geng Y; Wu J; Hannafon BN; Ding WQ
Free Radic Biol Med; 2015 Aug; 85():33-44. PubMed ID: 25908445
[TBL] [Abstract] [Full Text] [Related]
5. The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer.
Song Z; Ren H; Gao S; Zhao X; Zhang H; Hao J
Tumour Biol; 2014 Nov; 35(11):11319-28. PubMed ID: 25119596
[TBL] [Abstract] [Full Text] [Related]
6. The hypoxia-inducible factor-1 regulates the microRNA185 expression through binding to hypoxia response elements sequence 2.
Song Z; Ren H; Gao S; Zhao T; Wang X; Zhang S; Zhao X; Jia L; Sun J; Hao J
Med Oncol; 2013 Dec; 30(4):756. PubMed ID: 24198204
[TBL] [Abstract] [Full Text] [Related]
7. [Genetics of pheochromocytoma].
Bausch B; Malinoc A; Maruschke L; Offergeld C; Gläsker S; Rischke HC; Brauckhoff M; Boedeker CC; Neumann HP
Chirurg; 2012 Jun; 83(6):511-8. PubMed ID: 22481546
[TBL] [Abstract] [Full Text] [Related]
8. Genetics of pheochromocytomas and paragangliomas.
Opocher G; Schiavi F
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163
[TBL] [Abstract] [Full Text] [Related]
9. Familial pheochromocytoma.
Erlic Z; Neumann HP
Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
[TBL] [Abstract] [Full Text] [Related]
10. Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations.
Ercolino T; Becherini L; Valeri A; Maiello M; Gaglianò MS; Parenti G; Ramazzotti M; Piscitelli E; Simi L; Pinzani P; Nesi G; Degl'Innocenti D; Console N; Bergamini C; Mannelli M
Clin Endocrinol (Oxf); 2008 May; 68(5):762-8. PubMed ID: 18031321
[TBL] [Abstract] [Full Text] [Related]
11. A meta-analysis of obesity and the risk of pancreatic cancer.
Berrington de Gonzalez A; Sweetland S; Spencer E
Br J Cancer; 2003 Aug; 89(3):519-23. PubMed ID: 12888824
[TBL] [Abstract] [Full Text] [Related]
12. Characterization of human mucin gene MUC4 promoter: importance of growth factors and proinflammatory cytokines for its regulation in pancreatic cancer cells.
Perrais M; Pigny P; Ducourouble MP; Petitprez D; Porchet N; Aubert JP; Van Seuningen I
J Biol Chem; 2001 Aug; 276(33):30923-33. PubMed ID: 11418607
[TBL] [Abstract] [Full Text] [Related]
